Use of Bedside Ultrasonography on the Incidence of Acute Renal Failure in High-risk Surgical Patients

Study Overview
=================
Brief Summary
-----------------
The mortality and postoperative complications of high risk surgeries vary in the different series. The management of this group of patients in intensive care unit (ICU) is fundamental to improve these outcomes. The objective of this study will be to evaluate whether the use of bedside ultrasound has an impact on the management of this group of patients with a consequent reduction in the incidence of acute renal failure in ICU and, secondarily, the incidence of associated complications. All adult patients (≥ 18 years old) admitted to ICU at Hospital das Clinicas of UFMG in the immediate postoperative period of major surgery with indication of ICU monitoring will be included and randomly randomized to the control or intervention group. The control group will be conducted by the intensive care physicians in charge without the US, while the second group will be conducted based in US findings. The US protocol will consist of a pulmonary US in four windows in each hemithorax , qualitative assessment of contractility and variation of inferior vena cava diameter. The primary outcome will be the development of acute renal failure as measured by the KDIGO score. Secondary outcomes will be length of ICU and hospital stay, ICU and 28 days mortality, length spent in mechanical ventilation, accumulated water balance, noradrenaline and dobutamine dose. Serum and urinary biomarkers will also be evaluated. Key words: ultrasound, high-risk surgery, intensive care

Detailed Description
-----------------
This is a single-center randomized clinical trial to be performed at the Adult Intensive Care Unit (ICU) of the Clinical Hospital of the Federal University of Minas Gerais, Belo Horizonte. The ICU is a clinical-surgical unit that has 18 beds with admission of approximately 100 patients per month, being 70% surgical patients and 30% clinical patients. Postoperative patients who meet the inclusion criteria reported below will be randomized to guide therapy according to ultrasound findings at the bedside versus a group that will not perform this method. Serum and urine samples will be collected in three times: admission (T0), after 12 hours (T1) and after 24 hours (T2) to analysed urine and serum biomarkers.

Official Title
-----------------
Use of Bedside Ultrasonography on the Incidence of Acute Renal Failure in High-risk Surgical Patients: Randomized Clinical Trial

Conditions
-----------------
Acute Kidney Injury

Intervention / Treatment
-----------------
* Other: Intervention Ultrasound Group


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Age equal or superior to 18 years. Major surgeries requiring ICU admission associated with one of the following criteria: Use of vasoactive drugs Use of inotropic drugs Mean blood pressure less than 65 mmHg or SBP <90 mmHg. Hyperlactatemia> 2 mmol / L Heart rate> 90 bpm. Invasive mechanical ventilation required for at least 6 hours at the time of inclusion. Hypoxia: satO2 <92% in ambient air. Length of surgery greater than 4 hours. Request for transfusion of blood products in a surgical block Oliguria during procedure, defined as diuresis <0.5 ml/kg/h. Exclusion Criteria: Patients who do not agree to the terms of the Dying patients with impending death in the first 24 hours Patients in a previous renal replacement therapy program

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Intervention Ultrasound Group<br>Patients will be submitted to Ultrasound protocol, namely: In the first 6 to 12 hours of admission to ICU Second US after 12-24 hours of inclusion. Third US after 24-48 hours of inclusion. Protocol: US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions. US inferior vena cava, collapsability or distensibility index according to the patient's conditions, in spontaneous or controlled ventilation, respectively. Cardiac US: subjective evaluation of contractility between normal, reduced or severely reduced. The US findings will be communicated to the attending physicians who will conduct the patient, according to the protocol, recommending the administration of volume or not, and the use of vasopressors and/or inotropic drugs. | Other: Intervention Ultrasound Group<br>* Protocol: US 4 pulmonary quadrants in each hemithorax: anterior and lateral, upper and lower regions (figure 1) US inferior vena cava, collaborative index or distensibility according to the patient's conditions, in spontaneous or controlled ventilation, respectively. Cardiac US: subjective evaluation of contractility in normal, discreetly reduced or severely reduced.<br>|
| No Intervention: Control Group<br>Patients randomized to this group will receive care according to the indication of the attending physicians, composed mainly of intensive care physicians, without bedside US. Patients may be submitted to echocardiographic, abdominal and vascular examinations, among others, requested to ultrasound service, according to the indication. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Acute renal failure (ARF) | Creatinine elevation or oliguria according to KDIGO classification Impact in the incidence of ARF in major surgeries | One week | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Volume replacement within the first 36 hours. | Quantity of volume administered during first 36 hours of admission in ICU | 36 hours | 
| Use of vasopressor drugs. | vasopressor drugs requirement mcg/kg/min | 36 hours | 
| Use of inotropic drugs. | Inotropic drug requirement in mcg/kg/min | 36hours | 
| Length of invasive mechanical ventilation | Days spent in invasive mechanical ventilation | 36 hours | 
| Length of ICU stay | Days spent in ICU | 28 days | 
| Length of Hospital stay | Days spent in Hospital | 28 days | 
| Mortality in ICU | Any cause of mortality during ICU stay | 28 days | 
| 28 days mortality | Any cause of mortality in 28 days | 28 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
ultrasound,, high-risk surgery, intensive care